Groundbreaking miDOC Technology Revolutionizes Glaucoma Surgery

Real-time ocular fluid monitoring promises to transform eye procedures with unprecedented precision.

Apr. 13, 2026 at 4:18am

Got story updates? Submit your updates here. ›

An abstract, geometric painting in soft colors depicting the complex fluid dynamics and biometric measurements of the eye, conceptually representing the precision and insights offered by the miDOC technology.A revolutionary surgical technology promises to transform eye procedures by providing real-time biometric feedback to surgeons.Mount Sinai Today

A revolutionary surgical technology called miDOC is poised to transform glaucoma and other eye surgeries by providing surgeons with real-time data on critical fluid dynamics within the eye during procedures. Developed by Dr. Sean Ianchulev, miDOC continuously measures parameters like pressure, flow, and ocular rigidity, allowing surgeons to make informed adjustments and tailor each surgery to the patient's unique needs. The New York Eye and Ear Infirmary of Mount Sinai has completed the first 20 successful cases in a first-in-human clinical study, showcasing miDOC's potential to elevate glaucoma surgery to a new era of digital-guided precision.

Why it matters

Glaucoma surgery has long been hindered by the lack of intraoperative ocular flow and pressure measurements, resulting in high failure rates and unpredictable outcomes. miDOC aims to bridge this gap, bringing glaucoma surgery up to par with the impressive 95% success rate of cataract interventions, which benefit from accurate biometry. By providing real-time insights, miDOC could significantly enhance the precision and success of glaucoma and other eye procedures.

The details

miDOC continuously monitors pressure, flow, outflow facility, and ocular rigidity/compliance during surgery, offering unprecedented real-time insight into how surgical interventions impact the eye. This level of biometric feedback is a game-changer, as it allows surgeons to make informed adjustments and tailor each procedure to the patient's unique needs. The first 20 cases completed at the New York Eye and Ear Infirmary of Mount Sinai have been successful, with all procedures guided by intraoperative biometric measurements.

  • The first 20 miDOC cases were completed in a first-in-human clinical study at the New York Eye and Ear Infirmary of Mount Sinai.
  • miDOC is set to be unveiled by Dr. Sean Ianchulev at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in 2026.

The players

Dr. Sean Ianchulev

A visionary ophthalmologist and the developer of the miDOC technology.

Dr. Gautam Kamthan

The co-inventor of the miDOC technology, which aims to transform surgical interventions by enabling high-precision biometry.

New York Eye and Ear Infirmary of Mount Sinai

The only eye center in the country to use miDOC, having successfully completed the first 20 cases in a first-in-human clinical study.

Got photos? Submit your photos here. ›

What they’re saying

“By providing real-time biometric feedback, miDOC has the potential to elevate glaucoma surgery to a new era of digital-guided precision.”

— Dr. Sean Ianchulev, Ophthalmologist and developer of miDOC

“The ability to measure aqueous outflow during surgery is a game-changer, opening doors to improved clinical outcomes and a new era of surgical precision.”

— Dr. Gautam Kamthan, Co-inventor of miDOC

What’s next

miDOC is currently investigational and awaits regulatory approval. If approved, the technology could revolutionize eye surgery, improving outcomes and patient experiences.

The takeaway

miDOC represents a significant advancement in ophthalmology, offering real-time insights and precision that were previously unattainable. This groundbreaking technology has the potential to transform glaucoma and other eye surgeries, ushering in a new era of digital-guided precision and improved patient outcomes.